PRESS RELEASE published on 09/27/2024 at 11:24, 1 year 5 months ago HALF-YEAR_FINANCIAL_REPORT_JUNE_2024
BRIEF published on 09/23/2024 at 19:41, 1 year 6 months ago GenSight Biologics Reports Interim Financial Results for H1 2024 Financial Results Cash Management LUMEVOQ® Early Access Program R&D Expenses
BRIEF published on 09/23/2024 at 19:41, 1 year 6 months ago GenSight Biologics publie ses résultats financiers intermédiaires pour le premier semestre 2024 Résultats Financiers LUMEVOQ® Programme D'accès Anticipé Dépenses De Recherche Et Développement Gestion De Trésorerie
PRESS RELEASE published on 09/23/2024 at 19:36, 1 year 6 months ago Inside Information / News release on accounts, results GenSight Biologics reports interim financial results for the first half of 2024, highlighting optimized cash management, extension of cash runway, and upcoming LUMEVOQ® drug product release Cash Management GenSight Biologics Interim Financial Results LUMEVOQ® Drug Product Release
PRESS RELEASE published on 09/23/2024 at 19:36, 1 year 6 months ago Informations privilégiées / Communiqué sur comptes, résultats GenSight Biologics publie ses résultats financiers du premier semestre 2024 avec une réduction des dépenses opérationnelles de 60% et l'extension de son horizon de trésorerie. Nouveau Directeur Administratif et Financier nommé Résultats Financiers GenSight Biologics Directeur Administratif Et Financier Dépenses Opérationnelles Horizon De Trésorerie
BRIEF published on 09/17/2024 at 14:45, 1 year 6 months ago Goldman Sachs vend ses actions GENSIGHT BIOLOGICS S.A. Euronext Paris Franchissement De Seuils Goldman Sachs Cession D'actions GenSight Biologics
BRIEF published on 09/17/2024 at 14:45, 1 year 6 months ago Goldman Sachs sells its GENSIGHT BIOLOGICS SA shares Euronext Paris Goldman Sachs Crossing Thresholds Transfer Of Shares GenSight Biologics
PRESS RELEASE published on 09/17/2024 at 14:40, 1 year 6 months ago Franchissement de seuils Déclaration de franchissement de seuils par The Goldman Sachs Group, Inc. concernant GENSIGHT BIOLOGICS S.A. sur Euronext Paris Euronext Paris Déclaration The Goldman Sachs Group Franchissement De Seuils GenSight Biologics
BRIEF published on 07/23/2024 at 07:35, 1 year 8 months ago GenSight Biologics Reports Financial Position and Business Progress Gene Therapy Financial Update GenSight Biologics LUMEVOQ Early Access Program
BRIEF published on 07/23/2024 at 07:35, 1 year 8 months ago GenSight Biologics présente sa situation financière et ses progrès commerciaux Thérapie Génique Mise À Jour Financière Produits Biologiques GenSight LUMEVOQ Programme D'accès Anticipé
Published on 03/24/2026 at 23:00, 17 minutes ago Redwood AI Selected to Present at BIO-Europe Spring 2026, Europe's Largest Springtime Biotech Partnering Event
Published on 03/24/2026 at 18:55, 4 hours 22 minutes ago Norse Gold Announces Closing of Private Placement Financing and Pending Reactivation on the TSX-V
Published on 03/24/2026 at 13:30, 9 hours 47 minutes ago GGL Resources Corp. Announces Closing of Earn-In Agreement with Nelson Resources Limited on Its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/24/2026 at 13:30, 9 hours 47 minutes ago Innodata Announces Date of Annual Shareholder Meeting
Published on 03/24/2026 at 12:35, 10 hours 42 minutes ago Silver X Acquires the High-Grade Pampas Gold-Silver Project, Expanding its Precious Metal Asset Base in Peru
Published on 03/24/2026 at 21:08, 2 hours 9 minutes ago Linedata Services: Linedata annonce le transfert de son contrat de liquidité auprès de Portzamparc (Groupe BNP Paribas)
Published on 03/24/2026 at 19:49, 3 hours 28 minutes ago EEII AG: Cancellation of the Extraordinary General Meeting of March 26, 2026
Published on 03/24/2026 at 19:41, 3 hours 35 minutes ago ASMALLWORLD Honoured with Regional Virtuoso Award in Continental Europe for “Most Engaged Member” in Recognition of Their Exceptional Contribution
Published on 03/24/2026 at 19:05, 4 hours 12 minutes ago WBS Power Advances 3.2 GW Energy Infrastructure for Hyperscale Data Center Campus
Published on 03/24/2026 at 18:39, 4 hours 37 minutes ago EQS-Adhoc: FORTEC Elektronik Aktiengesellschaft: Adjustment of the earnings forecast for the financial year 2025/2026
Published on 03/24/2026 at 17:46, 5 hours 31 minutes ago NRJ GROUP - Press release annual results 2025